This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Olsen, R. G. Articles by Wolff, L. H. Search for Related Content PubMed PubMed Citation Articles by Olsen, R. G. Articles by Wolff, L. H.

Abrogation of Resistance to Feline Oncornavirus Disease by Immunization with Killed Feline Leukemia Virus¹

Department of Veterinary Pathobiology, The Ohio State University, Columbus, Ohio 43210

Four-week-old specific-pathogen-free cats were immunized with a combined vaccine composed of killed feline leukemia virus and killed feline oncornavirus-associated cell membrane antigen-containing tumor cells. Immunization induced feline oncornavirus-associated cell membrane antigen antibody titers ranging from 1:32 to 1:256 but did not elicit detectable virus-neutralizing antibody titers. Kittens immunized with tumor cells alone developed higher feline oncornavirus-associated cell membrane antigen antibody titers (ranging from 1:512 to 1:2048) than those given the combined vaccine.

All kittens were challenged with virulent Snyder-Theilen feline sarcoma virus at 12 weeks of age. Seventy-five % of the kittens vaccinated with combined vaccine and 67% of unvaccinated control kittens developed progressive fibrosarcomas after challenge. By contrast, none of the kittens vaccinated with killed tumor cells alone developed progressive fibrosarcomas after challenge. The combined vaccine did not, however, inhibit the induction of feline leukemia virus viremia.

¹ Supported by Contract NO1 5-3571 within the Virus Cancer Program of the National Cancer Institute, NIH, USPHS.

Received 12/28/76. Accepted 4/ 4/77.